Neoadjuvant Immunotherapy Plus CRT Versus Neoadjuvant CRT for Locally Advanced Resectable ESCC | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Neoadjuvant Immunotherapy Plus CRT Versus Neoadjuvant CRT for Locally Advanced Resectable ESCC	Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, digestive system disorder, digestive system neoplasm, epithelial neoplasm, esophageal disorder, esophageal squamous cell carcinoma, neoplasm, squamous cell carcinoma, squamous cell neoplasm	Recruiting	Phase 2 / Phase 3	2022-06-30		NCT04973306

16 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Cancer Institute and Hospital, Chinese Academy of Medical Sciences	294
First Affiliated Hospital of Wenzhou Medical University	117
Fudan University	653
Ningbo Medical Center Lihuili Hospital	61
Peking University Cancer Hospital & Institute	189
Shanghai Chest Hospital	116
Shanghai Minhang Central Hospital	10
Shanghai Zhongshan Hospital	347
Sichuan Cancer Hospital and Research Institute	64
Sun Yat-sen University	606
The First People's Hospital of Changzhou	35
Tianjin Medical University Cancer Institute and Hospital	287
Tongji Hospital	276
Xuhui Central Hospital, Shanghai	9
Zhejiang Cancer Hospital	142
Zhongshan Hospital (Xiamen), Fudan University	8

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Shanghai Zhongshan Hospital	Shanghai	China	5